C83.16 Mantle cell lymphoma, intrapelvic lymph nodes

Name of the Condition

• Mantle cell lymphoma, intrapelvic lymph nodes
• Also known as ICD-10 code C83.16

Summary

Mantle cell lymphoma, intrapelvic lymph nodes, is a type of non-Hodgkin lymphoma characterized by the malignant proliferation of B-cells originating from the mantle zone of lymphoid follicles. It specifically involves abnormal growth of these cells in the intrapelvic lymph nodes. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior.

Causes

The exact cause of mantle cell lymphoma, intrapelvic lymph nodes, remains unknown. It is thought to involve genetic mutations, such as the t(11;14)(q13;q32) translocation, which leads to overexpression of cyclin D1. Specific triggers or environmental factors are not well-defined, though research suggests potential links to immune system dysregulation.

Risk Factors

• Age: More common in older adults, typically over 60 years.
• Male gender: Slightly higher incidence in males.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the pelvic region.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.
• Abdominal or pelvic pain or fullness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI) to assess lymph node involvement, and biopsy of the affected tissue. Pathological examination confirms the presence of mantle cell lymphoma, often with immunohistochemical staining for cyclin D1. Additional tests, such as bone marrow biopsy or PET scans, may be used to stage the disease.

Treatment Options

Treatment depends on the stage and aggressiveness of the disease. Options may include chemotherapy, targeted therapy (e.g., BTK inhibitors), immunotherapy, or stem cell transplantation. Radiation therapy may be used for localized disease. Treatment plans are tailored to the individual patient’s condition and overall health.

Prognosis and Follow-Up

Prognosis varies based on factors like age, overall health, and disease stage. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term management may involve ongoing treatment or surveillance.

Complications

Potential complications include disease progression, involvement of other organs, treatment-related side effects (e.g., infection risk from chemotherapy), and reduced quality of life due to symptoms or therapy.

Lifestyle & Prevention

No specific preventive measures are known. Maintaining a healthy lifestyle, avoiding known carcinogens, and managing chronic infections may support overall health. Regular medical check-ups are recommended for early detection.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or pelvic pain. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

Use code C83.16 for mantle cell lymphoma specifically involving intrapelvic lymph nodes. Ensure documentation supports the anatomical site (intrapelvic lymph nodes) to justify code assignment. Verify that the diagnosis aligns with pathological and clinical findings to avoid coding errors.